Olah C - Search Results

1

Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer.

Olah C, Sichward L, Hadaschik B, Darr C, Grünwald V, Krafft U, Grünwald BT, Mahmoud O, Al-Nader M, Nyirady P, Reis H, Szarvas T. Olah C, et al. BJU Int. 2025 Jan 13. doi: 10.1111/bju.16643. Online ahead of print. BJU Int. 2025. PMID: 39801278

2

High-soluble CGA levels are associated with poor survival in bladder cancer.

Szarvas T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, Nyirády P, Oláh C, Széll T, Csizmarik A, Hadaschik B, Reis H. Szarvas T, et al. Among authors: olah c. Endocr Connect. 2019 May 1;8(5):625-633. doi: 10.1530/EC-19-0068. Endocr Connect. 2019. PMID: 30999279 Free PMC article.

3

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik B, Olah C, Krege S, Nyirády P, Szendröi A, Szücs M, Módos O, Székely E, Reis H, Szarvas T. Krafft U, et al. Among authors: olah c. Urol Oncol. 2019 Nov;37(11):810.e7-810.e15. doi: 10.1016/j.urolonc.2019.04.015. Epub 2019 Apr 30. Urol Oncol. 2019. PMID: 31053526

4

STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.

Krafft U, Tschirdewahn S, Hess J, Harke NN, Hadaschik BA, Nyirády P, Szendröi A, Szücs M, Módos O, Olah C, Székely E, Reis H, Szarvas T. Krafft U, et al. Among authors: olah c. Pathol Oncol Res. 2020 Apr;26(2):1243-1249. doi: 10.1007/s12253-019-00689-y. Epub 2019 Jun 27. Pathol Oncol Res. 2020. PMID: 31250373 Free article.

5

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.

Olah C, Tschirdewahn S, Hoffmann MJ, Krafft U, Hadaschik B, Nyirady P, Szendröi A, Módos O, Csizmarik A, Kovalszky I, Reis H, Szarvas T. Olah C, et al. Diagnostics (Basel). 2020 Oct 23;10(11):864. doi: 10.3390/diagnostics10110864. Diagnostics (Basel). 2020. PMID: 33114033 Free PMC article.

6

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.

Szarvas T, Hoffmann MJ, Olah C, Szekely E, Kiss A, Hess J, Tschirdewahn S, Hadaschik B, Grotheer V, Nyirady P, Csizmarik A, Varadi M, Reis H. Szarvas T, et al. Among authors: olah c. Diagnostics (Basel). 2020 Dec 31;11(1):48. doi: 10.3390/diagnostics11010048. Diagnostics (Basel). 2020. PMID: 33396213 Free PMC article.

7

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.

Krafft U, Olah C, Reis H, Kesch C, Darr C, Grünwald V, Tschirdewahn S, Hadaschik B, Horvath O, Kenessey I, Nyirady P, Varadi M, Modos O, Csizmarik A, Szarvas T. Krafft U, et al. Among authors: olah c. Cancers (Basel). 2021 May 22;13(11):2548. doi: 10.3390/cancers13112548. Cancers (Basel). 2021. PMID: 34067347 Free PMC article.

8

A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes.

Olah C, Hahnen C, Nagy N, Musial J, Varadi M, Nyiro G, Gyorffy B, Hadaschik B, Rawitzer J, Ting S, Sjödahl G, Hoffmann MJ, Reis H, Szarvas T. Olah C, et al. Int J Cancer. 2022 Mar 1;150(5):856-867. doi: 10.1002/ijc.33809. Epub 2021 Oct 2. Int J Cancer. 2022. PMID: 34536301

9

Neoadjuvant cisplatin-based chemotherapy in "primary" and "secondary" muscle-invasive bladder cancer-is it a surrogate for molecular subtypes?

Szarvas T, Olah C, Reis H. Szarvas T, et al. Among authors: olah c. Transl Cancer Res. 2019 Mar;8(Suppl 2):S176-S179. doi: 10.21037/tcr.2019.01.05. Transl Cancer Res. 2019. PMID: 35117093 Free PMC article. No abstract available.

10

Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.

Kovács PT, Mayer T, Csizmarik A, Váradi M, Oláh C, Széles Á, Tschirdewahn S, Krafft U, Hadaschik B, Nyirády P, Riesz P, Szarvas T. Kovács PT, et al. Among authors: olah c. Biomedicines. 2022 Mar 17;10(3):698. doi: 10.3390/biomedicines10030698. Biomedicines. 2022. PMID: 35327500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters